

This center treats substance use disorders and co-occurring mental health conditions. Your treatment plan addresses each condition at once with personalized, compassionate care for comprehensive healing.
Offering intensive care with 24/7 monitoring, residential treatment is typically 30 days and can cover multiple levels of care. Length can range from 14 to 90 days typically.
This provider hasn't verified their profile's information. Are you the owner of this center? Claim your listing to better manage your presence on Recovery.com.
This center treats substance use disorders and co-occurring mental health conditions. Your treatment plan addresses each condition at once with personalized, compassionate care for comprehensive healing.
Offering intensive care with 24/7 monitoring, residential treatment is typically 30 days and can cover multiple levels of care. Length can range from 14 to 90 days typically.
If you have any questions about the extent of insurance coverage, we strongly recommend that you contact your insurance carrier to determine potential coverage available for treatment.
Located in the peaceful countryside of Petersham, Massachusetts, this residential program helps adults recovering from substance use and co-occurring disorders. It serves individuals who have already completed detox and need continued support. The facility sits near Quabbin Reservoir and Harvard Forest, offering nature trails and quiet surroundings. A car is recommended for travel, as public transportation is limited.
The center uses a structured, evidence-based approach that includes therapies such as cognitive behavioral therapy (CBT) and integrated group therapy. Patients receive both group and individual counseling, along with medication consultations if needed. These methods help people understand their behaviors, manage emotions, and build lasting skills for recovery from substance use and mental health issues.
Patients benefit from a calm setting, comfortable accommodations, and access to on-site wellness activities. The program includes peer support groups and trauma-informed care. Staff create personalized recovery plans and help with aftercare options. McLean’s team also offers family involvement and support to help strengthen long-term recovery at home.

This center treats substance use disorders and co-occurring mental health conditions. Your treatment plan addresses each condition at once with personalized, compassionate care for comprehensive healing.
The Joint Commission accreditation is a voluntary, objective process that evaluates and accredits healthcare organizations (like treatment centers) based on performance standards designed to improve quality and safety for patients. To be accredited means the treatment center has been found to meet the Commission's standards for quality and safety in patient care.

Medication-Assisted Treatment (MAT) is an evidence-based approach that pairs FDA-approved medications with counseling to treat addiction. The medications are used to reduce cravings, ease withdrawal symptoms, or block the effects of substances. More about MAT

Dolophine®, Methadose®
Methadone is a full opioid agonist, meaning it activates opioid receptors in the brain to produce effects like pain relief and euphoria. It is longer acting than many other opioids, making it useful in medication-assisted treatment for opioid use disorder.
It reduces withdrawal symptoms and cravings by occupying opioid receptors without causing intense highs. Because it is a full agonist, it must be used carefully to avoid overdose, but it is highly effective when taken as prescribed within a structured program.

Vivitrol®, Revia®
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors in the brain and prevents opioids from producing effects like euphoria or sedation. It is used to treat both opioid and alcohol use disorders, but does not cause physical dependence or withdrawal.
It helps reduce cravings and the rewarding effects of opioids or alcohol, supporting long-term recovery. Because it blocks opioid effects, it should only be started after a person has fully detoxed from opioids to avoid triggering withdrawal.